Drug Type Prophylactic vaccine |
Synonyms Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine(Sanofi Pasteur) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metapneumovirus infection | Phase 1 | AU | 17 Sep 2024 | |
Parainfluenzae virus infection | Phase 1 | AU | 17 Sep 2024 | |
Respiratory Syncytial Virus Infections | Phase 1 | AU | 17 Sep 2024 |